Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent
Crossref DOI link: https://doi.org/10.1186/s13045-016-0258-1
Published Online: 2016-03-31
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Leonard, Jessica T.
Raess, Philipp W.
Dunlap, Jennifer
Hayes-Lattin, Brandon
Tyner, Jeffrey W.
Traer, Elie https://orcid.org/0000-0001-8844-2345
Funding for this research was provided by:
Leukemia and Lymphoma Society (LLS SCOR)